APPG on Heart and Circulatory Diseases

The All-Party Parliamentary Group (APPG) on Heart and Circulatory Diseases exists to provide a forum for parliamentarians to work with experts across the health sector, patients and organisations to improve health outcomes for people living with heart and circulatory diseases in the UK.

The British Heart Foundation provides secretariat support to the APPG to assist with its mission of ensuring that heart and circulatory diseases remain on the political agenda, so that together we can beat the heartbreak these conditions cause families and loved ones every day.

In recent years, the BHF and the APPG have worked together to raise awareness of heart and circulatory diseases amongst parliamentarians, and have run inquiries and produced reports on issues such as heart failure.

Most recently, the APPG produced the ‘Putting patients at the heart of artificial intelligence’ report after running an inquiry on the impact of artificial intelligence technologies on heart and circulatory disease patients. The inquiry examined patient perspectives on the use of artificial intelligence (AI) in healthcare through a series of roundtable discussions with patients, policymakers, cardiologists, researchers and industry representatives.

The APPG also conducted a survey to find out what the public know and feel about the use of artificial intelligence technologies in providing healthcare to those with heart and circulatory diseases. 

Findings from the survey showed that 91% of people with heart and circulatory diseases think that the public should be well informed about the use of AI in the healthcare sector. As a result of this, the report presents a case for actively engaging patients and the public during the development and adoption of AI.

The report highlights six key recommendations:

  1. NHSX should set up discussions with charities and the public, to explore patients’ views and concerns about the use of AI in healthcare.
  2. Understanding Patient Data (UPD) should work with charities, patients and the healthcare sector to develop tools and resources for engaging the public on AI.
  3. Academic Health Science Networks should facilitate the exchange of information around new developments in AI between patients charities, and industry partners.
  4. NHS England and NHS Digital should explore the impact of wearables and AI on health inequalities.
  5. NHSX should work with UPD, charities, and patient organisations to ensure that policy development in AI is designed with the explicit purpose of understanding, promoting and protecting public values and that this is clearly and openly communicated.
  6. NHS England and NICE should develop standards for publication for AI research, providing trustworthy guidelines for researchers, the media and the public.
For more information, you can read the summary or full report